Reducing Presystemic Drug Metabolism

作者: Majid Y. Moridani

DOI: 10.1002/9783527633166.CH9

关键词: PharmacologyDrug metabolismChemistryBiochemistry

摘要:

参考文章(75)
Barbara Haeberlin, Werner Rubas, Harold W. Nolen III, David R. Friend, In vitro evaluation of dexamethasone-β-D-glucuronide for colon-specific drug delivery Pharmaceutical Research. ,vol. 10, pp. 1553- 1562 ,(1993) , 10.1023/A:1018956232628
Josias H Hamman, Gill M Enslin, Awie F Kotz??, Oral delivery of peptide drugs: barriers and developments. BioDrugs. ,vol. 19, pp. 165- 177 ,(2005) , 10.2165/00063030-200519030-00003
Munir A. Hussain, Bruce J. Aungst, Eli Shefter, Prodrugs for Improved Oral β-Estradiol Bioavailability Pharmaceutical Research. ,vol. 5, pp. 44- 47 ,(1988) , 10.1023/A:1015863412137
Harold W. Nolen III, David R. Friend, Menthol-β-D-Glucuronide: A Potential Prodrug for Treatment of the Irritable Bowel Syndrome Pharmaceutical Research. ,vol. 11, pp. 1707- 1711 ,(1994) , 10.1023/A:1018950930134
H. -J. Horst, W. J. H�ltje, M. Dennis, A. Coert, J. Geelen, K. D. Voigt, Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Journal of Molecular Medicine. ,vol. 54, pp. 875- 879 ,(1976) , 10.1007/BF01483589
Thomas N. Tozer, Jean Rigod, Andrew D. McLeod, Ramon Gungon, M. Kim Hoag, David R. Friend, Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig. Pharmaceutical Research. ,vol. 8, pp. 445- 454 ,(1991) , 10.1023/A:1015838825437
TORSTEN EHRIG, WILLIAM F. BOSRON, TING-KAI LI, Alcohol and aldehyde dehydrogenase. Alcohol and Alcoholism. ,vol. 25, pp. 105- 116 ,(1990) , 10.1093/OXFORDJOURNALS.ALCALC.A044985